natgillin/translations-raw huggingface dataset:
10 x 1 tablets in PVC/aluminium perforated unit dose blister.
10 x 1 tablete v perforiranem pretisnem omotu za enkratni odmerek PVC/aluminij.
10 x 10 doses
10 x 10 odmerki
10 x 10 doses
10 x 10 odmerkov
10 x 10 doses (10 x 20 ml) 25 doses (50 ml)
10 x 10 odmerkov (10 x 20 ml) 25 odmerkov (50 ml)
10 x 10 doses (20 ml)
10 x 10 odmerkov (20 ml)
10 x 10 doses (20 ml) 1 x 25 doses (50 ml) 1 x 50 doses (100 ml)
10 x 10 odmerki (20 ml) 1 x 25 odmerki (50 ml) 1 x 50 odmerki (100 ml)
10 x 10 tablets
10 x 10 tablet
10 x 100 doses
10 x 100 odmerki
10 x 100 doses (10 x100 ml)
10 x 100 odmerkov (10 x 100 ml)
10 x 10ml bottle
10 x 10 ml steklenička
10 x 150 doses
10 x 150 odmerki
10 x 2 doses (1 ml)
10 x 2 odmerka (1 ml)
10 x 20 ml bottle
10 x 20 ml steklenička
10 x 25 doses
10 x 25 odmerki
10 x 25 doses
10 x 25 odmerkov
10 x 25 doses (10 x 50 ml)
10 x 25 odmerkov (10 x 50 ml)
10 x 25 doses (50 ml)
10 x 25 odmerkov (50 ml)
10 x 3 ml cartridges
10 x 3 ml injekcijski vložki
10 x 3 ml pre-filled pens
10 x 3 ml napolnjeni injekcijski peresniki
10 x 5 doses
10 x 5 odmerkov
10 x 50 doses
10 x 50 odmerki
10 x 50 doses
10 x 50 odmerkov
10 x 50 doses (10 x 50 ml) 100 doses (100 ml)
10 x 50 odmerkov (10 x 50 ml) 100 odmerkov (100 ml)
10 x 50 doses (100 ml)
10 x 50 odmerkov (100 ml)
10 x 50 ml bottle
10 x 50 ml steklenička
10 x 500 doses
10 x 500 odmerkov
10 yrs < 18 yrs
10 let < 18 let
10 µg
10 mcg
10 µg + 20 µg
10 mcg + 20 mcg
10 – 15 cm
PREDEL
10 – 15 cm from groin
10–15 cm nad kolenom
10 – 15 cm from groin
10–15 cm od dimelj
10% points from
znotraj 10 % od
10% threshold
10-% prag
10, 20 or 100 tablets
10, 20 ali 100 tablet
10, 20, 30 or 40 doses) and flashing lock symbol.
10, 20, 30 ali 40 odmerkov) in simbol ključavnice utripa.
10, 20, 30 or 40 doses).
10, 20, 30 ali 40 odmerkov).
10, 25, 50 or 125 ml bottle.
Plastenke po 10, 25, 50 ali 125 ml.
10, 30, 100, 130 and 175 tablets.
10, 30, 100, 130 in 175 tablet.
10, 30, 100, 130, 175 and 250 tablets.
10, 30, 100, 130, 175 in 250 tablet.
10, 32 or 100 ml bottle with two syringes per presentation.
10, 32 ali 100 ml steklenička z dvema merilnima brizgama v vsakem pakiranju.
10, av. de La Ballastière 33500 Libourne
10 avenue de La Ballastière 33500 Libourne
10, av. de La Ballastière 33500 Libourne FRANCE
10, av. de La Ballastière 33500 Libourne Francija
10,000 birds with an average bodyweight of 1 kg).
10.000 ptic s povprečno telesno težo 1 kg).
10,000 birds with an average bodyweight of 100 g).
10.000 ptic s povprečno telesno težo 100 g).
10,000 doses
10000 odmerkov
10,000 IU
10.000 i.e
10,000 IU/1 ml
10.000 i.e./1 ml
10,000 IU/ml:
10.000 i.e./ml:
10,000 U tenecteplase per vial
10.000 enot tenekteplaze na vialo
10,000 units
10.000 enot
10,000 units*
5.000 enot*,
10,057 patients undergoing treatment of UA or NSTEMI ACS
10.057 bolnikih, ki so se zdravili zaradi akutnega koronarnega sindroma (UA ali NSTEMI).
10,830 nM (920 to 3,970 ng/ml), treatment of HIV-2 infection with rilpivirine is not recommended in the absence of clinical data.
2.510 do 10.830 nmol/l (920 do 3.970 ng/ml), vendar za zdravljenje okužbe s HIV-2 uporaba rilpivirina ni priporočena, saj o tem ni kliničnih podatkov.
10-20% none
10-20
10-minute intravenous infusion of [90Y]-radiolabelled Zevalin solution.
10-minutna intravenska infuzija raztopine z [90Y] označenega zdravila Zevalin.
10.
Lot
10.0 (7.3 to 10.3)
10,0 (7,3-10,3)
10.0 ml (1 dose=
10,0 ml (1 odmerek=
10.0 ml once daily
10,0 ml enkrat na dan
10.0 ml twice daily
10,0 ml dvakrat na dan
10.0 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate.
10,0 ml/100 kg telesne mase) , po potrebi v kombinaciji z antibiotičnim zdravljenjem ali s peroralno rehidracijsko terapijo.
10.0 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate.
10,0 ml/100 kg telesne mase), po potrebi v kombinaciji z antibiotičnim zdravljenjem ali s peroralno rehidracijsko terapijo.
10.1 kg to 20 kg
10,1 kg - 20 kg
10.2 cm x 10.2 cm units or four 5.1 cm x 10.2 cm units should remain in the body as there is only limited long-term experience with larger quantities.
10,2 cm, saj so dolgoročne izkušnje z uporabo večjih količin zdravila omejene.
10.2 mm, round, normal convex, white film-coated tablets debossed “OZ” over “10” on one side and “G” on the other side.
10,2 mm, okrogle, obojestransko izbočene, bele filmsko obložene tablete z vtisnjeno oznako “OZ” nad “2.5”na eni strani in “G” na drugi strani.
10.2d (7.5, NR)
10,2d (7,5, ND)
10.3 (12.4)
bolečina v prsnih bradavicah
10.4 (8.6 –
ty i 0.7
10.4 months 9.0 - 12.0
10,4 meseca
10.4 vs.
10,4 v primerjavi z 2,9
10.5 % of the radiolabelled dose was recovered, with urine (81.3  11.1 %) representing the primary route of excretion compared to faeces (10.1  1.5 %).
14C-nevirapina, se je izločilo približno 91,4  10,5 % radioaktivno označenega odmerka, pri čemer je bila glavna pot izločanja s sečem (81,3  11,1 %) v primerjavi z blatom (10,1  1,5 %).
10.5 % of the radiolabelled dose was recovered, with urine (81.3  11.1%) representing the primary route of excretion compared to faeces (10.1  1.5 %).
14C-nevirapina, se je izločilo približno 91,4  10,5 % radioaktivno označenega odmerka, pri čemer je bila glavna pot izločanja s sečem (81,3  11,1 %) v primerjavi z blatom (10,1  1,5 %).
10.5 (11.5)
S1255P (2)
10.5 (11.5)
Zvišanja transaminaz
10.5 mg once daily
10,5 mg enkrat na dan
10.5 mg twice daily
10,5 mg dvakrat na dan
10.5 months in the Cyramza plus docetaxel arm and 9.1 months in the placebo plus docetaxel arm.
9,1 meseca v skupini s placebom in docetaksel.
10.5 to 12 kg
10,5 do 12 kg
10.5 to 12 kg*
10,5 do 12 kg
10.8 (9.5 – 12.1)
er 0.3 er 0.3 j
10.8 m vs 3.8m
10,8 m v prim. s 3,8 m
10.8 ml water for injections
10,8 ml vode za injekcije
10.8% [95% CI: 5.5, 18.5]) in the chemotherapy group, (n=102), with an ORR difference of 15.0% (95% CI: 6.0, 22.2).
10,8 % [95 % interval zaupanja: 5,5; 18,5]) v skupini s kemoterapijo (n=102) z razliko deleža objektivnega odziva 15,0 % (95 % interval zaupanja: 6,0; 22,2).
10.92 ml/min/1.73 m2 at 36 months.
10,92 ml/min/1,73 m2 po 36 mesecih.
10.SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
POSEBNI VARNOSTNI UKREPI ZA ODSTRANJEVANJE NEUPORABLJENIH ZDRAVIL ALI IZ NJIH NASTALIH ODPADNIH SNOVI, KADAR SO POTREBNI
100
100 i.
100 % (1 IU/mL)
100 % (1 i.e./ml)
100 % of previous dose
100% predhodnega odmerk a
100 % of previous dose
100% predhodnega odmerka
100 (10 x 10 x 1) tablets (unit dose) (multipack)
100 (10 x 10 x 1) tablet (enkratni odmerek) (večkratno pakiranje)
100 (10 x 10 x 1) tablets (unit dose) (multipack)
100 (10 x 10 x1) tablet (enkratni odmerek) (večkratno pakiranje)
100 (2 x 50 x 1)
100 (2 x 50 x 1) kapsul
100 ampoules: solvent
100 ampul: vehikel
100 capsules
EU/1/15/1012/039
100 coated tablets
100 obloženih tablet
100 day (for HDPE 100’s count)
100 dni (za HDPE vsebnike s 100 tabletami)
100 day (for HDPE 200’s count)
100 dni (za plastenke iz polietilena visoke gostote po 200 kapsul)
100 dispersible tablets
100 disperzibilnih tablet
100 doses
1 x 100 odmerki
100 doses
100 odmerki
100 film coated tablets
100 filmsko obloženih tablet
100 film-coated tablets
100 filmsko obloženih tablet.
100 film-coated tablets
30 filmsko obloženih tablet 100 filmsko obloženih tablet
100 film-coated tablets 28x1 film-coated tablets 50x1 film-coated tablets
28x1 filmsko obložena tableta 50x1 filmsko obložena tableta
100 hard gastro-resistant capsules (5 cartons of 20 capsules) 500 hard gastro-resistant capsules (25 cartons of 20 capsules)
100 trdih gastrorezistentnih kapsul (5 škatel po 20 kapsul) 500 trdih gastrorezistentnih kapsul (25 škatel po 20 kapsul)
100 international units insulin human (30% as soluble insulin and 70% as isophane insulin) (equivalent to 3.5 mg),
100 mednarodnih enot humanega insulina (30 % v obliki topnega insulina in 70 % v obliki insulina izofan) (kar ustreza 3,5 mg),
100 international units soluble insulin human*/isophane (NPH) insulin human* in the ratio 30/70 (equivalent to 3.5 mg).
100 mednarodnih enot topnega humanega insulina*/humanega insulina izofan (NPH)* v razmerju 30/70 (kar ustreza 3,5 mg).
100 IU (200 IU/mL) recombinant follicle-stimulating hormone (FSH) activity.
100 i.e. (200 i.e./ml) aktivnosti rekombinantnega folikle stimulirajočega hormona (FSH).
100 IU per ml and 40 IU per ml) must not be mixed.
100 i.e./ml in 40 i.e./ml) ne smemo mešati.
100 IU per ml and 40 IU per ml) must not be mixed.
100 i.e./ml in 40 i.e./ml) se ne sme mešati.
100 IU/0.5 mL
100 i.e./0,5 ml
100 IU/kg once every 10 days, adjust interval based on individual response.
100 i.e./kg enkrat vsakih 10 dni, presledek prilagodite glede na bolnikov odziv.
100 IU/ml
100 i.e./ml
100 IU/ml
40 i.e./ml
100 IU/ml
EU/1/97/030/002
100 IU/ml
EU/1/97/030/005
100 IU/ml
EU/1/97/030/018
100 IU/ml
EU/1/97/030/020
100 IU/ml
EU/1/97/030/034
100 IU/ml
EU/1/97/030/035
100 IU/ml
EU/1/97/030/069
100 IU/ml
EU/1/97/030/110
100 IU/ml
EU/1/97/030/111
100 IU/ml
EU/1/97/030/169
100 IU/ml
EU/1/97/030/170
100 IU/ml
raztopina za injiciranje
100 IU/ml
ubkutana uporaba
100 IU/ml
uspenzija za injiciranje
100 IU/ml after reconstitution with 5 ml solvent.
100 i.e./ml po rekonstituciji s 5 ml vehikla.
100 IU/mL after reconstitution)
100 i.e./ml po rekonstituciji)
100 IU/ml after reconstitution).
100 i.e./ml po rekonstituciji).
100 mg
gastrorezistentna
100 mg (1 orange 80 mg capsule and 1 grey 20 mg capsule)
100 mg (1 oranžna 80 mg kapsula in 1 sive 20 mg kapsula)
100 mg (2.5 ml) twice daily
100 mg (2,5 ml) dvakrat na dan
100 mg / day*
100 mg/dan
100 mg /day (in two divided doses)
100 mg/dan (v dveh deljenih odmerkih)
100 mg cream contains 5 mg imiquimod
100 mg kreme vsebuje 5 mg imikvimoda.
100 mg daily + Victrelis 800 mg
100 mg dnevno + zdravilo Victrelis 800 mg trikrat na dan)
100 mg daily taken as 50 mg in the morning and 50 mg in the evening if you are taking Galvus alone, with another medicine called metformin or a glitazone, with a combination of metformin and a sulphonylurea, or with insulin.
100 mg na dan, ki ga vzamete v odmerkih 50 mg zjutraj in 50 mg zvečer, če jemljete zdravilo Galvus samostojno, skupaj z drugim zdravilom, ki se imenuje metformin ali glitazon, v kombinaciji z metforminom in sulfonilureo ali z insulinom,
100 mg daily taken as 50 mg in the morning and 50 mg in the evening if you are taking Jalra alone, with another medicine called metformin or a glitazone, with a combination of metformin and a sulphonylurea, or with insulin.
100 mg na dan, ki ga vzamete v odmerkih 50 mg zjutraj in 50 mg zvečer, če jemljete zdravilo Jalra samostojno ali skupaj z drugim zdravilom, ki se imenuje metformin ali glitazon, v kombinaciji z metforminom in sulfonilureo ali z insulinom,
100 mg daily taken as 50 mg in the morning and 50 mg in the evening if you are taking Xiliarx alone, with another medicine called metformin or a glitazone, with a combination of metformin and a sulphonylurea, or with insulin.
100 mg na dan, ki ga vzamete v odmerkih 50 mg zjutraj in 50 mg zvečer, če jemljete zdravilo Xiliarx samostojno ali skupaj z drugim zdravilom, ki se imenuje metformin ali glitazon, v kombinaciji z metforminom in sulfonilureo ali z insulinom,
100 mg film-coated tablets: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, iron oxide yellow (E172), iron oxide black (E172).
100 mg filmsko obložene tablete: polivinilalkohol, titanov dioksid (E171), makrogol 3350, smukec, rumeni železov oksid (E172), črni železov oksid (E172).
100 mg once a day
100 mg enkrat dnevno
100 mg once daily (n=315)
Liraglutid+ 1,8 mg na dan (n=300)
100 mg once daily, Cmax is in the order of 1.1-1.5 µg/ml and trough levels were 0.015-0.020 µg/ml.
100 mg enkrat dnevno, se Cmax giblje v intervalu med 1,1 in 1,5 μg/ml, najnižje koncentracije pa so 0,015 do 0,020 μg/ml.
100 mg Outer Carton
100 mg – zunanja škatla
100 mg prednisolone
100 mg prednizolona
100 mg QD1
100 mg enkrat na dan1
100 mg single-use vial containing powder for concentrate for infusion solution delivers 5 mL of 20 mg/mL of trastuzumab emtansine after reconstitution (see section 6.6).
Po rekonstituciji 100-mg viale za enkratno uporabo s praškom za koncentrat za raztopino za infundiranje dobimo 5 ml trastuzumaba emtanzina s koncentracijo 20 mg/ml (glejte poglavje 6.6).
100 mg single-use vial containing powder for concentrate for infusion solution delivers 5 mL of 20 mg/mL of trastuzumab emtansine after reconstitution.
Po rekonstituciji 100-mg viale za enkratno uporabo s praškom za koncentrat za raztopino za infundiranje dobimo 5 ml trastuzumaba emtanzina 20 mg/ml.
100 mg suspension for injection
100 mg suspenzija za injiciranje
100 mg tablet
100 mg tablete
100 mg three times a day
100 mg trikrat dnevno
100 mg to 300 mg twice a day), emtricitabine/tenofovir alafenamide (200 mg/25 mg once daily)5,6
na 300 mg dvakrat dnevno), emtricitabin/alafenamidtenofovir at (200 mg/25 mg enkrat dnevno)5,6
100 mg trastuzumab emtansine vial: Using a sterile syringe, slowly inject 5 mL of sterile water for injection into the vial.
100-mg viala trastuzumaba emtanzina: S sterilno injekcijsko brizgo počasi injicirajte v vialo 5 ml sterilne vode za injekcije.
100 mg twice a day
100 mg dvakrat dnevno
100 mg twice daily
300 mg enkrat na dan
100 mg valnemulin base per 1 g
100 mg čistega valnemulina na 1 g
100 mg vial has a shelf life of 3 years.
Rok uporabnosti 100 mg viale je 3 leta.
100 mg/ 25 mg tablets – Carton of 1 bottle
100 mg/25 mg tablete - škatla z 1 plastenko
100 mg/25 mg tablets - bottle label
100 mg/25 mg tablete – nalepka na plastenki
100 mg/25 mg/200 mg or 125 mg/31.25 mg/200 mg or 150 mg/37.5 mg/200 mg or
75 mg/18,75 mg/200 mg ali 100 mg/25 mg/200 mg ali 125 mg/31,25 mg/200 mg ali
100 mg/25 mg/200 mg or 125 mg/31.25 mg/200 mg or 175 mg/43.75 mg/200 mg or
75 mg/18,75 mg/200 mg ali 125 mg/31,25 mg/200 mg ali 150 mg/37,5 mg/200 mg ali
100 mg/25 mg/200 mg, 125 mg/31.25 mg/200 mg and 150 mg/37.5 mg/200 mg.
100 mg/25 mg/200 mg, 125 mg/31,25 mg/200 mg in 150 mg/37,5 mg/200 mg.
100 mg/25 mg/200 mg, 125 mg/31.25 mg/200 mg and 150 mg/37.5 mg/200 mg.
100 mg/25 mg/200 mg,125 mg/31,25 mg/200 mg in 150 mg/37,5 mg/200 mg.
100 mg/25 mg/200 mg, 125 mg/31.25 mg/200 mg and 150 mg/37.5 mg/200 mg.
Deset tablet zdravila Corbilta 150 mg/37,5 mg/200 mg je enako 375 mg karbidope na dan.
100 mg/25 mg/200 mg, 125 mg/31.25 mg/200 mg or 150 mg/37.5 mg/200 mg tablets, do not take more than 10 tablets each day.
100 mg/25 mg/200 mg, 125 mg/31,25 mg/200 mg ali 150 mg/37,5 mg/200 mg tablete, ne vzemite več kot 10 tablet dnevno.
100 mg/day*
100 mg/dan
100 mg/ml Concentrate for
koncentrat za raztopino za infundiranje
100 mg/m² administered as a 30-minute to three-hour intravenous infusion, followed by the continuous intravenous infusion of 5-fluorouracil (F) 1000 mg/m²/day from day 1 to day 4.
1. dan, ki mu je sledil cisplatin (P) 100 mg/m2 v 30-minutni do 3-urni intravenski infuziji in nato stalna intravenska infuzija 5-fluorouracila (F) 1000 mg/m2/dan od 1. do 4. dneva.
100 mg/tenofovir 300 mg once daily,
100 mg/tenofovir 300 mg
100 mg: 56 and 98 orodispersible tablets
100 mg: 56 in 98 orodisperzibilnih tablet
100 micrograms fentanyl (as citrate)
100 mikrogramov fentanila (v obliki citrata)
100 micrograms labelling is purple
50 mikrogramov, ovojnina je oranžna 100 mikrogramov, ovojnina je vijolična
100 micrograms PRE-FILLED SYRINGES LABEL
NALEPKA ZA NAPOLNJENO INJEKCIJSKO BRIZGO 100 mikrogramov
100 micrograms/dose labelling is purple
100 mikrogramov/odmerek, ovojnina je vijolična
100 microlitres dispersion/kg and multiple doses up to 150 microlitres dispersion/kg were tolerated well in Phase I clinical trials.
V kliničnih preskušanjih I. faze so bolniki dobro prenesli posamične odmerke do 100 mikrolitrov disperzije/kg in večkratne odmerke do 150 mikrolitrov disperzije/kg.
100 milligram (1.2 milliliter)
100 miligramov (1,2 mililitra)
100 ml
100 ml steklenička
100 ml (1 measuring syringe)
100 ml (1 merilna brizga)
100 ml (100 doses)
100 ml (100 odmerkov)
100 ml (50 doses)
100 ml (50 odmerkov)
100 ml 100 % orange juice
100 ml 100-% čistega pomarančnega soka .
100 ml amber glass bottle (with child-resistant polypropylene screw cap, outer part: polyethylene; inner part: polypropylene; liner: polyethylene) with 13 g of powder for oral suspension, a plastic adapter (low density polyethylene) , plastic 3 ml oral dispenser (0.1 ml graduation) and 10 ml oral dispenser (0.5 ml graduation) (barrel and plunger: polypropylene, silicon based seal ring) and a plastic measuring cup (polypropylene).
100-ml steklenica iz jantarjevega stekla (z za otroke varno polipropilensko zaporko z navojem, zunanji del: polietilen, notranji del: polipropilen, obloga: polietilen) s 13 g praška za peroralno suspenzijo, plastični nastavek (polietilen nizke gostote), plastični 3-ml peroralni odmernik (skala po 0,1 ml) in 10- ml peroralni odmernik (skala po 0,5 ml) (brizga in bat: polipropilen, tesnilo na osnovi silikona) in plastično merilno čašo (polipropilen).
100 ml and 250 ml bottle
100 ml in 250 ml steklenička
100 ml and 250 ml HDPE bottles
100 ml in 250 ml HDPE stekleničke
100 ml bottle
100 ml steklenička
100 ml Cyclic Olefin Polymer (COP) plastic bottle, fitted with a chlorobutyl/butyl rubber stopper and aluminium cap fitted with blue plastic flip off disc.
100 ml plastenka iz cikloolefinskega polimera (COP), zaprta z zamaškom iz klorobutil/butil gume in z aluminijasto zaporko z z modro plastično snemno zaporko.
100 ml Cyclic Olefin Polymer (COP) plastic bottle, fitted with a chlorobutyl/butyl rubber stopper and aluminium cap fitted with violet plastic flip off disc.
100 ml plastenka iz cikloolefinskega polimera z zamaškom iz klorobutila/butila in pečatom iz aluminija z vijolično plastično dvižno zaporko.
100 ml glass bottle Bottle adaptor
100 ml steklenica nastavek za steklenico
100 ml infusion bags should be considered for patients who are susceptible to fluid volume overload and weigh less than 20 kg; in this case the infusion rate (ml/min) should be decreased so that the total duration remains no less than 4 hours.
Za bolnike, ki so občutljivi na volumsko preobremenitev in tehtajo manj kakor 20 kg, je treba uporabiti 100 ml vsebnike infuzijske raztopine natrijevega klorida in v tem primeru zmanjšati hitrost infuzije tako, da celotna infuzija ne traja manj kot 4 ure.
100 ml infusion bags should be considered for patients who are susceptible to fluid volume overload and weigh less than 20 kg; in this case the infusion rate (ml/min) should be decreased so that the total duration remains no less than 4 hours.
Za bolnike, ki so občutljivi na volumsko preobremenitev in tehtajo manj kakor 20 kg, je treba uporabiti vsebnik s 100 ml infuzijske raztopine natrijevega klorida in v tem primeru zmanjšati hitrost infuzije tako, da celotna infuzija ne traja manj kot 4 ure.
100 ml multilayer polyolefin/styrene-ethylene-butylene (SEB) bag with SFC polypropylene infusion port closed with rubber stopper and snap cap.
100 ml večplastna, vreča iz poliolefin/stiren-etilen-butilena (SEB) z SFC propilenskim nastavkom za infundiranje, zaprtim z gumijastim zamaškom in snemno zaporko.
100 ml or 250 ml bottle.
Plastenka po 100 ml ali 250 ml.
100 ml PET vials, clear Stoppers: Bromobutyl rubber stoppers Caps: Flanged caps
Zamašek: Bromobutlni gumijasti zamaški Zaporke: Zarobljene zaporke
100 ml plastic bottle
100 ml plastenka
100 ml polypropylene bags with a polypropylene twist-off port fitted with a cap, with a polyester/polypropylene overwrap
100 ml polipropilenske vreče s polipropilenskim odtržnim vhodom, na katerem je pokrov, z zunanjo ovojnino z poliestra/polipropilena
100 ml solution in colourless glass bottle type I with fluoropolymer coated halobutyl rubber stopper and aluminium flip-off cap.
100 ml raztopine v brezbarvni steklenici iz stekla tipa I, zaprti z zamaškom iz halobutilne gume, prevlečene s fluoropolimerom, in z aluminijasto odtržno zaporko.
100 ml) final
100 ml)
100 ml, 2 x 100 ml and 200 ml bottle
100 ml, 2 x 100 ml in 200 ml steklenička
100 ml, 200 ml,
1 steklenička,
100 ml, 250 ml bottle
plastenka po 100 ml, 250 ml
100 mL/hour
100 ml/uro
100 or 250 ml bottle with a measuring syringe.
Vsebnik po 100 ml ali 250 ml.
100 orodispersible tablets
100 orodisperzibilnih tablet
100 patient years of use.
0,8 zlomov na 100 bolnikov-let uporabe zdravila.
100 patients [(naïve (n=29); or previously treated with agalsidase beta who switched to Replagal (n=71)) were treated for up to 30 months in an open label, uncontrolled study.
100 bolnikov [predhodno nezdravljenih (n = 29) ali predhodno zdravljenih z agalzidazo beta, ki so prešli na zdravilo Replagal (n = 71)] se je do 30 mesecev zdravilo v odprti nenadzorovani študiji.
100 pipettes
100 kapalk
100 pre-filled syringes
100 napolnjenih injekcijskih brizg
100 tablets
100 tableti
100 tablets
100 x 1 tablet
100 tablets
30tablet 100 tablet
100 tablets
50 tablet
100 tablets
90 tablet
100 tablets
Bolniki z jetrno okvaro
100 tablets
EU/1/11/706/027
100 tablets
PODATKI NA ZUNANJI OVOJNINI
100 tablets
uporaba
100 tablets: EU/1/08/469/005
100 tablet: EU/1/08/469/005
100 tablets: EU/1/08/469/010
100 tablet: EU/1/08/469/010
100 tablets: EU/1/08/469/015
100 tablet: EU/1/08/469/015
100 tablets: EU/1/08/469/020
100 tablet: EU/1/08/469/020
100 tablets: EU/1/08/469/025
100 tablet: EU/1/08/469/025
100 tablets: EU/1/10/632/022
100 tablet: EU/1/10/632/022
100 tablets: EU/1/10/632/023
100 tablet: EU/1/10/632/023
100 tablets: EU/1/10/632/024
100 tablet: EU/1/10/632/024
100 Tasigna 300 mg twice daily (n = 282)
100 Tasigna 300 mg 2x/dan (n = 282)
100 to 119.9 kg
100 do 119,9 kg
100 U/kg
100 e/kg
100 U/ml
100 e./ml
100 U/ml
100 enot/ml
100 U/ml (3.5 mg/ml)
100 i.e./ml (3,5 mg/ml)
100 U/ml /
100 e./ml /
100 Units/ml
100 enot/ml
100 Units/ml
napolnjenem
100 units/ml (3.5 mg/ml)
100 enot/ml (3,5 mg/ml)
100 units/mL + 3.6 mg/mL, then look at the illustrations below to get to know the different parts of your pen and needle.
100 enot/ml + 3,6 mg/ml, nato pa se s pomočjo slik v nadaljevanju seznanite z različnimi deli injekcijskega peresnika in injekcijske igle.
100 VIAL AND 100 AMPOULES
100 VIAL IN 100 AMPUL
100 vials
10 vial
100 vials
100 vial
100 vials (multidose)
100 vial (večodmerna)
100 vials (multidose)
100 vial (večodmerne)
100 vials + 100
100 vial +100 vial
100 vials of lyophylisate and 100 vials of solvent (100 doses)
100 vial z liofilizatom in 100 vial z vehiklom (100 odmerkov)
100 vials: powder
100 vial: prašek
100 Weeks
100. teden
100 x 1 (Unit dose)
100 x 1 (enoodmerno pakiranje)
100 x 1 (unit dose)
100 x 1 (enota odmerka)
100 x 1 capsules (unit dose)
100 x 1 kapsula
100 x 1 capsules (unit dose)
100 x 1 kapsula (posamezni odmerek)
100 x 1 capsules (unit dose)
Kapsule, trde
100 x 1 film-coated tablet
100 x 1 filmsko obložena tableta
100 X 1 film-coated tablet
100 X 1 filmsko obloženih tablet
100 x 1 film-coated tablets
100 x 1 filmsko obložena tableta
100 x 1 hard capsules
100 x 1 trda kapsula
100 x 1 hard gastro-resistant capsules
100 x 1 trda gastrorezistentna kapsula
100 x 1 tablet
100 x 1 tablet (enoodmernih pretisnih)
100 x 1 tablet
100x1 tablet
100 x 1 tablet
30 x 1 tablet
100 x 1 tablet (unit
100 x 1 tableta (enkratno
100 x 1 tablet (unit dose)
100 x 1 tableta (enkratno odmerjanje)
100 x 1 tablets
100 tablet
100 x 1 tablets
100x1 tablet
100 x 1 tablets (unit
100 x 1 tableta
100 x 1 tablets (unit dose)
100 x 1 tableta (enkratni
100 x 1 tablets (unit dose)
100 x 1 tableta (enkratni odmerek)
100 x 1 tablets (unit dose)
100 x 1 tableta (enoodmerni pretisni omoti)
100 x 1 tablets (unit dose)
100 x1 tableta (enkratni odmerek)
100 µg / spray
100 µg / odmerek pršila
100% of previous dose
100 % predhodnega odmerka
100% oxygen
100% kisik
100% sevoflurane
100 % sevofluran
100-101 Terrasse Boieldieu Tour Franklin- La Défense 8 92042 Paris la Défense Cedex FRANCE
100­101 Terrasse Boieldieu Tour Franklin­ La Défense 8 92042 Paris la Défense Cedex FRANCIJA
100-200 mg TID
100-200 mg 3-krat na dan
1000
+ Met 1000
1000 Brussels Belgium
1000 Bruselj Belgija
1000 Brussels Belgium medinfoeuceemea@shire.com
1000 Bruselj Belgija medinfoeuceemea@shire.com
1000 doses
1 000 odmerkov
1000 doses
1.000 odmerkov
1000 doses (3-100 spheres) 5000 doses (3-100 spheres) 10000 doses (3-100 spheres)
1.000 odmerkov (3-100 kroglic) 5.000 odnerkov (3-100kroglic) 10.000 odmerkov (3-100 kroglic)